Cvijic Christine Mikail — SEC Form 4 filings
SEC reporting owner CIK 1543663. 11 Form 4 filings on record with FilingPulse; latest filed 2026-07-07.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-03-14 to 2026-07-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 24,000 shares, $491,400 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 13 legs across 7 filings — 35,104 shares, $976,270 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: purchase of 24,000 shares @ $20.48 ($491,400) in Neurogene Inc., filed 2024-11-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Neurogene Inc. (NGNE) | President and CFO, Director | 11 | 1 leg · 24,000 sh · $491,400 | 13 legs · 35,104 sh · $976,270 | 6 |
Form 4 filings — Cvijic Christine Mikail
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-07 | 4 | Neurogene Inc. (NGNE) | Sale (S): 600 @ $36.02 · Sale (S): 4,200 @ $36.13 | EDGAR |
| 2026-07-02 | 4 | Neurogene Inc. (NGNE) | Sale (S): 739 @ $34.06 · Sale (S): 2,531 @ $34.58 · Sale (S): 1,530 @ $35.23 | EDGAR |
| 2026-05-08 | 4 | Neurogene Inc. (NGNE) | Sale (S): 4,800 @ $30.07 · Sale (S): 4,800 @ $32.44 | EDGAR |
| 2026-03-30 | 4 | Neurogene Inc. (NGNE) | Sale (S): 2,558 @ $21.62 | EDGAR |
| 2026-03-17 | 4 | Neurogene Inc. (NGNE) | Sale (S): 2,387 @ $20.42 · Sale (S): 1,395 @ $21.25 · Sale (S): 263 @ $22.02 | EDGAR |
| 2026-03-03 | 4 | Neurogene Inc. (NGNE) | Sale (S): 4,800 @ $25.11 | EDGAR |
| 2026-02-24 | 4 | Neurogene Inc. (NGNE) | Grant/award (A): 22,000 @ $0 · Grant/award (A): 131,900 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | Neurogene Inc. (NGNE) | Grant/award (A): 20,300 @ $0 · Grant/award (A): 122,000 (derivative) @ $0 | EDGAR |
| 2025-03-17 | 4 | Neurogene Inc. (NGNE) | Sale (S): 4,501 @ $16.94 | EDGAR |
| 2024-11-25 | 4 | Neurogene Inc. (NGNE) | Purchase (P): 24,000 @ $20.48 | EDGAR |
| 2024-03-14 | 4 | Neurogene Inc. (NGNE) | Grant/award (A): 31,903 @ $0 · Grant/award (A): 53,900 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1543663 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →